Name: PharmaSynergy Autumn
Start: 21/09/2021 10:00 PM +00:00
End: 08/10/2021 09:00 PM +00:00

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals, and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on Twitter @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce.
&nbsp;

Abbott 

Abdi İbrahim is proud to be the guiding enterprise of the Turkish pharmaceutical industry with a deeply ingrained mission of healing since 1912. We strive to achieve our ambitious goals as we take pioneering and innovative leaps for our country and industry. Driven with resolution, we are striving to further Abdi İbrahim&rsquo;s goal of becoming a powerful international player, while at the same time reinforcing our market leader position in Turkey, which we have occupied continuously since 2002. Abdi Ibrahim has subsidiaries / affiliates in more than 6 countries globally and also owns 100% of Abdi Farma which is based in Portugal. ABDI FARMA is a wholly-owned subsidiary of Abdi Ibrahim and was established as the marketing authorization holder of all Abdi Ibrahim products aimed at European markets. With this strategy, ABDI FARMA registered 7 molecules in 8 EU countries to sell via distributors and also licensed several products to international companies with exclusive supply agreements to strengthen its foothold in this new geographic territory. ABDI FARMA aims to serve European markets with high-quality medicine at an affordable price and will aim to reflect Abdi Ibrahim&rsquo;s 110 years old experience to its new markets.&nbsp; As of January 2022, ABDI FARMA will be entering the second phase of its expansion and organically branching out its operation by opening its first subsidiary &ndash; Abdi Farma GmbH- in Germany..

Abdi Ibrahim Pharmaceuticals

Abiogen is an Italian pharmaceutical company dedicated to the development, manufacturing, and marketing of products in the muscle-skeletal area, including pain, and in other therapeutic areas as dermatology and respiratory. Abiogen sells its product in Italy directly with its sales organization. A large network of partners distributes Abiogen's products in several countries worldwide. Now Abiogen has recently undertaken the goal of expanding its commercial presence in some key European countries.

Abiogen Pharma

Acino is a Swiss company headquartered in Zurich with production sites near Basel and in Kiew, Ukraine as well as a packaging site in Estonia. Focus is on own marketing of branded generics in emerging markets (MEA, ESA, UKR/CIS, LATAM, RUS) as well as out-licensing of inhouse or externally developed generics to EU customers.
Regional offices are in Dubai, Johannesburg, Panama, Kyiv and Moscow. Acino is also a strong partner for contract manufacturing with respect to niche products and technologically complex formulations.

ACINO

Adare Pharma Solutions is a technology-driven CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical industry. Adare&rsquo;s specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 40 products sold by customers in more than 100 countries globally.
&nbsp;

Adare Pharma Solutions

We are involved in the registration, importation, marketing, sales and distribution of pharmaceutical products, medical equipment, and medical devices items.&nbsp;

Al-Hilal Drug Store

ALEXXIA PHARMA 

ALIBABA GROUP'S MISSION IS TO MAKE IT EASY TO DO BUSINESS ANYWHERE. We provide the fundamental technology infrastructure and marketing reach to help merchants, brands and other businesses that provide products, services, and digital content to leverage the power of the Internet to engage with their users and customers. Our businesses are comprised of core commerce, cloud computing, digital media and entertainment, innovation initiatives, and others. Through investee affiliates, we also participate in the logistics and local services sectors.

Alibaba Group

Founded in Cambridge (UK), Altacor Pharma was established in 2006 as a speciality ophthalmology company With an excellent reputation in the UK, it has achieved strong growth with a focus on ocular surface disease and surgical products. (mixture of own products and distributor/in-licensing) Acquired by privately owned company in 2014, it is now part of large pharmaceutical group. Altacor is expanding globally with a network of distributors Altacor future growth: Looking for new product distribution opportunities (in-license) Growing portfolio within by developing our own products (out-license) International expansion through elected partners and distributors Looking for investors for phase II product in development .

Altacor Limited

Athena aspires to be a global leader in pharma, innovation and drug delivery. It aspires to be a partner of choice for multinational pharmaceutical companies for their life cycle management requirement for mature products with a mission to enhance value to patients and improve compliance which is critical for any treatment.

ATHENA PHARMACEUTIQUES

Aurora Europe, headquartered in Berlin, Germany, is a subsidiary of Aurora Cannabis Inc., a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. Aurora Europe supplies high-quality medical cannabis products to patients throughout Europe. In 2015, Aurora entered the German market and today operates one of the largest authorised importers and distributors of medical cannabis in Europe. Aurora&rsquo;s internal network of EU GMP facilities continues to bring high-quality, premium medical cannabis to patients worldwide.&nbsp;

Aurora Europe

Aveom Pharma is a business development consulting company, we are MANDATED by clients to:
1/ SEARCH FOR HOSPITAL INNOVATIVE/GENERIC + OPPORTUNITIES in the field of Anaesthesia/Ressuscitation, orphan, pediatrics, neonates, pain management, critical care, Infectious diseases
2/ SEARCH FOR PERFORMANT DISTRIBUTORS &nbsp;WORLDWIDE for the following specialties:
* INNOVATIVE INJECTABLE for HOSPITAL in PAIN MANAGEMENT/CRITICAL CARE&nbsp;
 * NICHE GENERICS for retail and hospital markets in different therapeutic areas (e.g. Alimentary Tract and Metabolism, Analgesics, Antinfective, Central Nervous System, Musculo-Skeletal System, Respiratory System)&nbsp;
* MEDICAL DEVICES &amp; FOOD SUPPLEMENTS, in the field of GI, Gyneco, ophthalmology, allergy/immunology, CNS/neurology, dentistry/oral. INNOVATIVE FORMULATIONS, UNIQUE MODE OF ACTION, CLINICAL EVIDENCE

AVEOM PHARMA

Pharmaceutical contract manifacturing business

Bernita pharma

bitop AG, a German company, is focused on the manufacturing and utilization of natural protective molecules, the so-called Extremolytes. For more than 20 years, bitop has explored and validated Ectoin&reg;, a naturally cell protecting molecule with excellent membrane-stabilizing and inflammation-reducing properties for human use. Build on this experience, a portfolio of unique and natural OTC medical devices and cosmetics has been developed. bitop&rsquo;s greatest value lies in the scientifically proven efficacy of its products and the natural and preservative-free formulations. Ectoin&reg; already proved its efficacy and marketability successfully in various health &amp; wellbeing products which treat and alleviate symptoms of diverse skin diseases (especially atopic dermatitis), cough&amp;cold, allergies, ophthalmology and female intimate care. These products are marketed under brands of experienced pharmaceutical partners in more than 50 countries worldwide by now. bitop offers its Ectoin&reg;-containing products on a B2B licensing basis to pharmaceutical companies worldwide.

bitop AG

Bosnalijek, the largest manufacturer of drugs in Bosnia and Herzegovina, was founded in 1951. The company has a diversified manufacturing program encompassing 176 drugs based on 90 different generic names. Bosnalijek manufactures a wide range of drugs for peroral, parenteral, and topical use with an effect on digestive system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular, nervous, and respiratory system, as well as systemic hormone drugs with the exception of sex hormones.

Bosnalijek d.d.

Chanelle Pharma is Ireland&rsquo;s largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products and a leading provider of generic human and animal pharmaceuticals worldwide. We are currently active in 96 countries worldwide, being a partner of choice in the development and manufacturing of pharmaceutical products to the world&rsquo;s leading human generic and animal health multinationals and distributors.&nbsp;
We are passionate about understanding and addressing the challenges facing our medical and veterinary customers and bringing them innovative and effective products and solutions.&nbsp;
Building on over 35 years of research and development, Chanelle Pharma is headquartered on an 18-acre campus in Loughrea, Co Galway, with three manufacturing facilities, four research and development laboratories, and a fifth R&amp;D laboratory in Jordan. The company employs 550 people across the globe.

Chanelle Pharma

Romanian family company, founded in 1990. Expertise in distribution of finished products having a solid distribution network built over 25 years. Expertise in Regulatory affairs and drug safety, marketing and sales with dedicated sales force (medical representatives), clinical studies and distribution with own warehousing and distribution facilities (including cool chain).&nbsp; Products distributed are Rx, Food supplements, Medical devices. International partnerships on long term with Merck KGaA (26 years of distribution, regulatory, marketing and promotion, launching and developing the GM&amp;E portfolio, 5 years developing sales of Erbitux), Merck SelbstMedikation, P&amp;G, Pohl Boskamp, MedTrust, Moleac, Merck Romania, Sakura, Alfa Ljinia, Novo Nordisk, Wella and others. Authorised ISO 9001:2015 Dakks Tuv Rheinland National top medium and small sized companies - awarded for several years as company no 1 and/or among top 10 in the category at national/regional level.&nbsp;

Chimimportexport Plurimex SRL

&nbsp;Coripharma is a European generic pharmaceutical company, built on solid heritage. Coripharma uses 100% renewable energy: Your product will be manufactured with ZERO CARBON emission.
The company&rsquo;s experienced team offers out-licensing and contract manufacturing services to pharmaceutical companies that demand the highest quality and service from a reliable European supplier.
Located in Iceland, inside Schengen and the European Economic Area (EEA), Coripharma&rsquo;s manufacturing site has an annual production capacity of about 1.2 billion tablets/capsules. With regular launches on day one, often as the first company to market after patents expired in Europe, the manufacturing site played an essential role in the growth story of Actavis.&nbsp;
Coripharma offers out-licensing of its own developed products and contract manufacturing to pharmaceutical companies in markets around the world.

Coripharma ehf

course5i.com

Devintec Pharma is a private and independent company based in Lugano.&nbsp;
&nbsp;
 Our business is based on advanced Research &amp; Development that leads to discovering, developing, and successively licensing innovative healthcare solutions such as substance-based medical devices, topical medical devices, cosmeceuticals, cosmetics and food supplements.
&nbsp;
 &nbsp;

DEVINTEC SAGL

DKSH is the leading Market Expansion Services Company in Healthcare in Asia, the company reached 6.1 bill USD sales in Healthcare employing nearly 10,000 people. We have affiliates across 13 countries in Asia (exl China and Japan) with more than 6,000 Sales and Marketing professionals. We do have also our Own Brands Division. Our portfolio is mainly driven through in-licensing. We are looking for potential collaborations to license innovative medicines and medical devices for the APAC markets.

DKSH

Emona Biopharma is a GMP company from Slovenia, that specialises in the developing and out-licensing of generic pharmaceuticals for the European markets. Our partners are pharmaceutical enterprises that license, register, and sell our products under their own marketing authorizations. Emona Biopharma offers pharmaceuticals to European marketing partners: solid forms OTCs and Rx, as well as a number of hospital injectables.

Emona Biopharma d.o.o.

Proud to be Italian, but with an eye towards the International market, we are a company operating in the Nutraceutical sector with the aim of improving the quality of life, offering innovative solutions to optimise health. To reach this goal we are constantly investing time and resources in scientific research with a major focus on all the makings of our land, which offers products of primary benefits for the well-being of the body. This is how we succeeded in patenting nutraceuticals based on a fully traceable Italian supply chain that gives value to its original land, bringing its benefits into the whole world.

Esserre Pharma

Extendis Pharma has been founded in Barcelona with the mission of bringing quality medicines, with European approval, to emerging markets. To achieve it we focus on: \r\n1. Acquisition of European Marketing Authorizations (MAs) of medicines that offer an improvement compared to the existing therapeutic arsenal in Emerging markets\r\n2. Management of the transfer of the MA observing Regulatory, Quality and Pharmacovigilance regulations\r\n3. Registration, Promotion and Distribution of medicines in Emerging Markets through a wide network of partners

Extendis Pharma

FRIKE GROUP is an independent and diversified contract manufacturer for pharmaceutical products. We are able to produce and fill semi-solid, fluid forms and suppositories.
FRIKE GROUP is the Holding of 5 individual production companies on 5 locations in Switzerland. We are Swissmedic and FDA certified

Frike Group

Gr&uuml;nenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better &ndash; and innovation is our passion. We are focussing all of our activities and efforts on working towards our vision of a world free of pain. Gr&uuml;nenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2020, Gr&uuml;nenthal achieved sales of &euro; 1.3 bn. Our company employs around 4,500 people worldwide. We work hard, challenge and support each other, and seek opportunities to learn while demonstrating integrity in everything we do. We encourage an entrepreneurial and proactive mindset, challenging the status quo and implementing innovative ideas. Join Gr&uuml;nenthal to experience the impact you can have on the lives of the patients we serve and on the results we achieve. Join forces, make an impact and innovate &ndash; for a world free of pain.

Grünenthal

Menarini Espa&ntilde;a is one of the group's strategic subsidiaries and &nbsp; is one of the top 13 companies in the Spanish pharmaceutical sector.
More than &nbsp;760 people who work in Spain , carry out their work mainly in the scientific-medical, production, commercial and research and development (R&amp;D) areas.
We produce 58 million units of drugs per year , of which we export 73%. In 2019, the turnover was 254 million euros.
Menarini Spain is made up of the companies Laboratorios Menarini, SA; A. Menarini Latin America, SLU; Menarini Consumer Healthcare, SAU; Guidotti Farma, SLU; Retrain, SAU and Laboratorios Fermon, SLU

Grupo Menarini- Spain

hameln is a family-owned company specialised in the world-wide sales and distribution of injectable hospital products under the hameln-brand. Through our sister company, we also offer R&amp;D and Regulatory Services amongst other services.&nbsp;

hameln pharma gmbh   

Hypera Pharma is the largest pharmaceutical company in Brazil and is present in all relevant segments of the sector. With a leading position in several categories, it offers high quality and safe products, continuously investing in innovation and growing sustainably, so that people can live longer and better. Hypera Pharma is organized into three large business units, leaders in the markets in which they are present: Prescription Products: Present in the main therapeutic classes in the country, it operates in Primary Care under the umbrella brand Mantecorp Farmasa. In this segment, it has a portfolio of highly recognized drugs recommended by the medical community, with products such as Predsim, Celestamine, Maxsulid, Diprospan, Mioflex-A, Addera D3. In dermocosmetics, it acts as Mantecorp Skincare, with products recommended by dermatologists and developed especially for the characteristics of the Brazilian population. This business unit is supported by a highly productive medical visitation team, which performs more than 260,000 visits to physicians per month. Consumer Health: It is the market leader in over-the-counter medications, with iconic brands recognized by Brazilians for decades, including Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, among others. The unit also operates in the nutritional and vitamin supplement segments, with brands such as Tamarine, Vitasay, Biot&ocirc;nico Fontoura and Zero-Cal, a Top of Mind brand for 14 consecutive years. It is the largest media investor in Brazil, with dozens of advertising campaigns each year in traditional and digital media. Similar and Generic: With Neo Qu&iacute;mica brand, the Brazilian family medicine, is a leader in the Similar and Generic markets in which it is present. Neo Qu&iacute;mica reaches more than 80% of homes in Brazil, fulfilling the mission of promoting access to health with quality products for the population. With a vision of the future and innovation, Hypera Pharma created Hynova, one of the largest and most modern pharmaceutical research centers in Brazil, which houses a team of highly qualified professionals, masters and doctors for the development of medicines, dermocosmetics and products for health, using state-of-the-art technology to be a pioneer in Brazil. The company's strength in the pharmaceutical market is supported by a large-scale and low-cost operation, centralized in the largest pharmaceutical operational complex in Latin America, located in An&aacute;polis, in Goi&aacute;s. Headquartered in S&atilde;o Paulo and listed on the Novo Mercado of BM&amp;FBovespa since 2008, Hypera Pharma has a team of approximately 6,500 employees.&nbsp;
&nbsp;

Hypera Pharmaceuticals

IBSS BIOMED S.A. is a research-driven company and pioneer in the use of innovative ingredients in pharmaceutical products. We have an advanced product portfolio in gynecology, food allergy, and dermatology, gastroenterology.

IBSS BIOMED S.A.

ILKO was founded by a pharmacist and honorary president Mustafa &Ouml;ncel, who has worked in the pharmaceutical industry for almost 50 years. The company is a subsidiary of Sel&ccedil;uklu Holding, which has strong institutions across various economic sectors. &Ouml;ncel is one of Turkey&rsquo;s second-generation pharmacists and has always been faithful to his vision of being useful to human health. Characterized by honesty, big thinking, foresightedness and courage, he founded the production plant of ILKO in Konya, thus blazing a trail and fulfilling a duty of loyalty to his hometown. The production facility which is the largest pharmaceutical manufacturing investment in Anatolia is placed in Konya Third Organized Industrial Zone. The company has its headquarters in Sancaktepe, Istanbul, and R&amp;D center &ndash; İlko Araştırma ve Geliştirme Merkezi A.Ş. &ndash; in Beytepe Technopark of Hacettepe University in Ankara.
&nbsp;

ILKO

Inpha is an Italian company, specialised in the development of innovative Nutraceuticals, characterised by a high scientific rationale.
The efficacy of our formulations is supported by clinical trials and protected by intellectual property.
The products are developed by our own ''sister company'' Inpha Research, applying to supplements a new scientific approach, based on the rigorous study of biomechanical and physiological mechanisms, supported by sophisticated pharmaceutical technologies in order to increase the absorption and bioavailability of every active ingredient

Inpha Duemila s.r.l

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence&trade; delivers powerful insights with speed and agility &mdash; enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. To learn more, visit&nbsp;

IQVIA

Italfarmaco, one of the leading Italian pharmaceutical groups, operates in both the pharmaceutical and the fine chemical industries. The company was founded in Milan in 1938. The Italfarmaco Group now markets ethical products in Italy, Spain, Portugal and Greece, where it employs a workforce of over 1400 and has a total turnover exceeding 300 million euros. Its products, all of which have a high therapeutic content, are mainly used in the cardiovascular, immuno-oncological, gynaecological, dermatological, orthopedic and neurological areas.
 &nbsp;

Italfarmaco

JGL is a pharmaceutical company founded in 1991 in Rijeka, Croatia started from a small laboratory for galenic preparations. 30 years later, JGL is an international pharma company employing over 1.000 people and with an annual turnover exceeding EUR 130 million. Whether directly or through local Partners, JGL has a footprint on over 40 markets. JGL is EU and Russian GMP certified manufacturer which develops and manufactures drugs and medicinal products in target therapeutic areas, with a focus on the senses. Our core technology is the sterile production of eye drops and nasal sprays. We are proud to partner with large multinationals, strong regional and local players across regions of EU, CIS, Middle East and Asia. The vision that inspires and guides us is described in our statement: JGL wants to become a global pharmaceutical company specialised in the development and production of value-added sterile products in the segment of ophthalmology and ENT, and a leader in the use of the sea for health purposes.
We are looking for partners to distribute JGL products or license JGL products under partner's preferred brand.

JGL d.d.

K&eacute;ri Pharma Group is specialized in the sales and marketing of RX and OTC products in the Hungarian market.
 We offer:
- diosmin 1000 mg filmcoated tablet for out-licensing or distribution (own development)&nbsp;
- in-depth knowledge of the Hungarian pharmaceutical market, professional marketing unit with strong specialized field force &nbsp;for companies intending to have market access in Hungary
 Projects Sought:
- partners interested in sourcing diosmin 1000 mg for their market
- in-licensing/distribution opportunities for Hungary in the following areas:
- innovative and specialty drugs, RX and OTC
- niche/specialty generics
- orphan generics
 Main focus:
 - urology
- angiology/vascular
- rheumatology
- gastroenterology
- endocrinology
- HIV treatment, infectology

Kéri Pharma

Khiron Life Sciences Corp. is positioned to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, the company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. Further information on the company can be accessed through the following link: www.khiron.ca
&nbsp;

Khiron Life Sciences

For nearly 200 years Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Today, our company offers an attractive portfolio of over 30 brands and nearly 200 products in Germany. Initially established in Austria and Central Europe, the Klosterfrau export sales network now also includes Central Eastern and Western Europe as well as countries in North America, Africa and Asia. Our portfolio ranges from well-known and established brands, such as Melissengeist&reg; / Melisana&reg;, neo-angin&reg; and nasic&reg;, to products for very specific indications. Klosterfrau relies above all on the healing power of nature, for this is what our company is based on. Klosterfrau continuously develops and improves its products as well as customises the product line to new trends, research results or changing social landscapes. Klosterfrau also conducts research to bring entirely new brands and products onto the market in order to make use of its potentials.

Klosterfrau Healthcare Group

&nbsp;
Labomed S.A. is a Greek privately owned CDMO service provider, originating from the merger of LaboServe S.A. (established in Dec.2016) and Documed Limited (established in May 2015). Focused on integrated pharmaceutical services for generics and added value medicines of oral liquid dosage forms, Labomed has already accumulated significant know-how, intellectual property rights and projects intended for commercialization in Europe and US, mainly through Out&ndash;licensing &amp; Supply model.
Our &lsquo;state-of-the-art&rsquo; manufacturing facilities (EU-GMP approved), headquartered in Athens, Greece, are supported by in-house QC laboratory, robust quality systems and a team of specialists and high experienced personnel. It is this combination of expertise and infrastructure that makes Labomed your preferred business partner for the development and manufacture of liquid products containing controlled substances (psychotropics and/or narcotics).&nbsp;
We offer licensing rights and optimized supply agreements for differentiated, tailor-made added value generic products. Amongst other, a proprietary pain management portfolio addressing moderate to severe pain, is available as unique presentations and drug combinations.&nbsp;
We integrate drug development capabilities with optimized, cost-effective manufacturing solutions, in order to streamline your pathway from the laboratory to the market. Our scientists pair decades of pharmaceutical development experience to assess, identify and implement the right solutions and help discover added value. Labomed goes beyond the expected, offering guidance backed by leading-edge technologies and expertise in product development, technical transfers and scale-up.
Having several patent applications submitted to EU &amp; US, 8 products already approved in EU, 11 products under registration, and 4 products in Pipeline, Labomed is currently expanding in the development and manufacture of Cytotoxic/ high potent products.

Labomed Pharmaceutical 

Lo. Li. Pharma International is a young and dynamic Italian pharmaceutical company, based in Rome, dedicated to out-licensing and distribution of products mainly focused on Gynecology and Fertility with recent activities even in Endocrinology and Urology.
We are engaged in the research, development, and marketing of original formulations supported by strong and rigorous scientific literature. The values inspiring our work are excellence and innovation.
The first international partnership was established in 2009, and up to now Lo. Li. Pharma International&rsquo;s products are available in more than 60 countries worldwide.

Lo.Li. Pharma International

Lynx2Market is a privately-owned life-sciences events and conferences organiser committed to helping executives that are working in the healthcare and pharmaceutical industry, and who are looking to grow their businesses in emerging and fast-changing markets.&nbsp;
Lynx2Market is an organiser of PharmaSynergy event.

Lynx2Market

Zeller is Switzerland&rsquo;s No.1 Brand among phytopharmaceuticals. Based on the vision of pharmacist and founder Max Zeller (1834-1912), we are passionate about evidence-based natural therapies and about inspiring people to take control of and invest in their wellbeing. We develop products and services that deliver a more natural approach to health, based on our expertise: from the seed to the finished product.
Max Zeller S&ouml;hne AG is a Swiss family-owned phytopharmaceutical company, specialized in the development, production, and marketing of phytopharmaceuticals with clinically proven efficacy, safety, and tolerability. Through research, rigorous processes, quality controls, and extensive product testing throughout our value chain, we place the utmost importance on maintaining the highest standards to deliver medicines that become doctors&rsquo; first choice in the first-line treatment.

Max Zeller Soehne AG

Maxmind Pharmautical S.L. is a Spanish Pharma company, 100% owned by Maxmind Biotechnology (Hainan). We are focused on In Licensing generics to export to China Market. We already have many agreements in place and products under registration from our partners in Europe and other markets. \r\n\r\nWe also focus on bringing to Europe some of our more interesting products, such as Insulins and medical devices.

Maxmind Pharmaceuticals

MedAgora is a service provider for pharmaceuticals, medical devices, food supplements, and cosmetics. We support our clients in finding licensing partners, distributors, and clients in all European markets (EU and non-EU) and all other medium and large markets worldwide.
&nbsp;
We find partners for companies that want to expand in new markets, and we find products and capabilities for companies looking into expanding their product portfolio.
We work on a product-based approach (partner search), as well as a capabilities-based approach (client search for development/manufacturing/other services).
&nbsp;
A. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Matchmaking. The quality of our service is based on a thorough match-making process (territory, capabilities, product profile, therapeutic areas + Client's specific requirements)&nbsp;
B. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Comprehensive coverage of each territory. Our network includes an outstanding number of potential partners/distributors &ndash; the products will be introduced to all absolutely all relevant potential partners in each territory.
C. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Our pricing is fixed. We charge 1,000 EUR &ndash; 3,000 EUR per market (based on market size) for 1-3 products. The price grows for each additional product. 50% down payment, 50% after project finalization, once we deliver enough substantial feedback and results to Client's reasonable satisfaction. We do not take any percentage from the product sales or licensing fees.
D. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Our timelines are fixed. The standard deadline is 3-4 months after project initiation. It is calculated based on a number of markets/products/capabilities.
E. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Our business model and deliverables are completely transparent. We do not require any protection clause. We deliver openly all potential partners to the Client from the beginning, with complete details.
&nbsp;
We have the capabilities to support your expansion efforts worldwide &ndash; we can explore the potential of your products/capabilities in a multitude of target markets and identify appropriate partners in each of them.&nbsp;
Please note that in addition, we can also support you with product registration/notification procedures and other regulatory compliance requirements, market by market.
&nbsp;

Medagora

MEDINOMICS HEALTH CARE PVT LTD was established in 2004 by a group of partners with years of experience in the pharmaceutical industry with a commitment to creating a better quality of life by providing high-quality formulations especially, but not limited to, in Niche segments like Nutraceuticals and Pharmaceuticals.&nbsp;
We are a star export house accredited by the Government of India. We are a specialized business development unit and have a presence in more than 30 countries around the globe. We also have a shareholding in a manufacturing unit which is based in Chennai under our group company Ocean Healthcare Pvt. Ltd.&nbsp;
&nbsp;
&nbsp;
For a young company like ours, it is usually difficult to offer a large basket of products to a client, and hence to cater to regulated markets we have a strategic tie-up with a manufacturing unit that is EU GMP and Health Canada approved. For us, manufacturing is specialized work, not a trading activity and we claim that we deliver only the best of quality products with the state of the art manufacturing. Our ultimate aim is to bring maximum value to our partners amid a constantly evolving regulatory and market environment.
Having an experienced team headed by industry professionals pooling in decades of experience, we are engaged in:
&bull; Out-licensing with supply arrangements
&bull; Marketing &amp; Distribution arrangements
&bull; Contract Services&nbsp;
At Medinomics, profitability, ecology, and responsibility are not competing for interests &ndash; they create a synergy that makes our products and our world much better. Having said that we are looking for a strategic partner for the product lines attached with this email. We hope that will add value to your organization and we can be on your preferred supplier list to do business.&nbsp;
&nbsp;

Medinomics Healthcare

Integrated into the network of our parent company, DKSH, Medinova is marketing the products at home and abroad. The regional focus is on Europe, Asia, and selected countries in Central and South America. The international marketing is coordinated by our Swiss headquarters, bringing our products via qualified partners to more than 65 countries today.
We have positioned the company as a niche provider with a clear emphasis on gynecology, dermatology, and other selected therapeutic fields. Building on our competences in the areas of prescription drugs (RX) as well as consumer healthcare products (OTC), Medinova has a solid base in the Swiss domestic market. Our long-standing successful international presence will be enlarged by entering into new markets consequently. Our motivation results from our customers&rsquo; demand for high quality products at competitive prices. The active further development of our products is part of our corporate identity.

Medinova AG

Pharma-Quality Cannabis Products MediPharm Labs, a contract and development and manufacturing company, brings a pharmaceutical perspective to the cannabis industry; working to internationally recognized pharma-quality standards, our cannabis products that are PURE, TRUSTED, and PRECISELY DOSABLE for patients and end consumers.

MediPharm Labs

We are a company with extensive experience in generic pharmaceuticals who offers a broad portfolio of products and intellectual property to other pharmaceutical companies. We have a proven track record in securing regulatory approval prior to patent expiries and have obtained marketing authorizations in over 140 countries to date. Our company draws on the development and manufacturing capabilities of its parent company, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), whose R&amp;D specialists maintain a strong development pipeline.

Medis

MedServa GmbH is a privately held networking company locaded in center of Europe in Freiburg / South Germany, between Basle and Strasburg, founded in 2001. We support small/medium sized HEALTHCARE companies with innovative products in internationalising their business in Europe, from Lisbon to Moscow, mainly CE Medical Devices, Nutraceuticals, Dermocosmetics and OTC products. Our aim is to reduce &ldquo;go to market&rdquo; time and costs for both partners in generating sales thus "Creating healthy business" in true win/win mode. We are not a consulting company, our focus is to produce sales opportunities.
Specialties: branding of healthcare products, European marketing

Medserva GmbH

Menarini Asia-Pacific is the regional hub of leading Italian pharmaceutical company Menarini Group. We combine the strengths of our global resources with local customer insights to bring the best medical innovations to hospitals and healthcare providers.\r\nDirectly present in 13 Asia-Pacific markets, we manage an extensive portfolio of proprietary healthcare brands and licensed brands from some of the world's leading biotech companies. From R&amp;D through to manufacturing, regulatory approvals and commercialization - we are there every step of the way.

Menarini Asia-Pacific

We offer expert consulting services along the value chain of cannabis and connect your cannabis business with experts, suppliers, partners &amp; clients.
Partners who are interested in getting active in cannabis and who would like to explore their possibilities

MJ Universe

Next Wave (India) is a Pharmaceutical Company established in 2006. The company was established with the sole aim of supporting the medical fraternity by manufacturing quality medicines. The company has the facility of manufacturing finished dosage forms of Tablets, Liquids, Capsules, and External Applications. The facility has been accredited with WHO-GMP and PIC/s-GMP certification and the world-class laboratory has been awarded GLP certification. The Company boasts of cGMP compliant Formulation Development Lab as a key strength for New Product Development.
A leading provider of contract manufacturing and product development services to top Indian &amp; MNC Pharmaceutical companies. The company along with its employees is dedicated to delivering quality products in the market, upscaling and manufacturing differentiated formulations.
Contract Manufacturing We have been a CMO partner for different domestic and international businesses. We are a quality manufacturer for custom manufacturing of finished formulations in Private Label. At Next Wave India, we have customised packaging options for tailormade solutions.
Product Development We have a Co-development model for better and transparent sharing of ideas and tech-transfer. We believe in an exclusive developmental model for each project maintaining accuracy and establishing reliability. We strictly follow ICH guidelines and international regulations.
In/Out Licensing We provide Out-Licensing Services of Marketing Authorisations for formulation patents. We also In-Licensing of Products for research and developmental processes. We often work in a Co-Marketing model for International Marketing.

NEXT WAVE (India)

Noventure is a Spanish company based in Barcelona, specialized in licensing innovative substance-based medical devices and specialized food supplements. We offer approved medical devices under CE Mark ready for marketing in UE as well as in other territories around the World, and high standard food supplements supporting physiological functions in Gastroenterology, Urogynaecology, Paediatrics &amp; Dermatology areas. Our innovative, substance‐based medical devices are a friendlier and effective solution for the patient. They have no pharmacological, metabolic, or chemical effect, and they respect physiological functions. Our specialized food supplements come in distinctive galenics, thereby increasing acceptability, adherence, and consumer experience.&nbsp;

Noventure

Perrigo Company plc, is a global consumer self-care company. Our vision is: To make lives better by bringing "Quality, Affordable Self-Care Products" that consumers trust everywhere they are sold. Founded in 1887 as a packager of home remedies, Perrigo has transformed to a self-company which enables the empowered consumer to treat conditions that can be self-managed. Perrigo is the world's largest manufacturer of over-the-counter ("OTC") self-care products and supplier of infant formulas for the store brand market. The Company also is a leading provider of branded OTC products throughout Europe. Perrigo, headquartered in Ireland, sells its products primarily in North America and Europe, as well as in other markets.

Perrigo

We provide unprecedented access to world-class pharmaceutical data, including consumption patterns, medicine shortages, European parallel import information, niche market locator information, and much more. The Pharma14 platform deals in the tracking of finished dosage formulations as well as business analysis tools. Pharma14 is committed to helping its members reach their goals by providing them with an innovative environment for their businesses to thrive. Our monthly updated database is home to over 65 countries.

Pharma k.s 14 

PharmaLinea develops and manufactures clinically supported private label food supplements, fit for best-quality brands and promotion through medical detailing. Our portfolio covers iron deficiency, immunity, urinary tract, pregnancy, and other health areas. Our products are present in over 40 markets worldwide and several have achieved market-leading positions. Companies from global groups, such as Stada or Teva, choose us because our products provide differentiation and the accompanying clinical evidence convinces doctors. We are one of the 15 leading companies in the Vitafoods Steering Committee and recipients of several awards for product taste.

PharmaLinea

Since we first opened our doors in 2013, we have focused single-mindedly on delivering high-quality branded prescription medicines to patients, prescribers and healthcare providers across the globe. We specialise in the late-stage activities of development, co-development, licensing and acquisition.
Within our strategic therapeutic areas, we have developed our own innovative medicines as well as niche speciality products, and we have acquired tried and trusted medicines and iconic brands from innovator pharma companies and breathed new life into them.
From a single office in Basildon, we have grown consistently year on year. This has enabled us to reinvest in our products, our brands, our people, and to give back to our communities.
Our goal is to be an agile and imaginative global specialty pharma business and a preferred partner for innovator pharma companies.

Pharmanovia

PharmExtracta has almost 30 years of history and it started from the experience of professionals in the pharmaceutical and nutraceutical sector who shared a great passion for pharmacological, phytotherapeutic, and nutritional sciences.\r\nPharmExtracta aims to support the needs of doctors, pharmacists, healthcare stakeholders, and patients to develop and offer new products in the nutraceutical, cosmeceutical, and medical device fields.\r\nAll the formulations have an innovative rationale based on a high level of scientific evidence in line with the most recent discoveries.\r\nWe have a portfolio of more than 60 products backed up by over 150 scientific publications.R&amp;D, product development and clinical are supported and partnered with Velleja Research &reg;, our scientific R&amp;D center based on the highest innovative approach to herbal medicine and nutraceuticals.\r\nPharmExtracta considers the biopharmaceutical phytotherapy as a pillar of its way of operating. It uses standardized and titrated pharmaceutical grade raw materials.\r\nThe selection of raw materials with the highest level of quality is combined with the use of the most modern pharmaceutical technologies to obtain highly innovative and performing formulations.\r\nOur organization employes more than 120 people active in product development, market access, marketing,regulatory and promotion through our team promoting the products to specialized doctors in Pediatrics, Gynecology, Gastroenterology, Internal Medicine.\r\n

PharmExtracta

Pizeta Pharma S.p.A. is a pharmaceutical company established in 2010 in Perugia, in the centre of Italy. İt is engaged in research, development and marketing of original formulations supported by strong and rigorous scientific literature; innovative and high quality therapeutic solutions for human's health and well-being, mainly in nutraceutical area. &nbsp; We closely collaborate with our business partners and with universities with the aim to develop new products and formulations for national and international market. Therapeutic areas covered : Gynaecology, Obstetrics and Fertility, Woman Health.&nbsp; During recent years, our commitment has expanded to others therapeutic areas such as, ophthalmological, cardiovascular, pediatric and dermatology.&nbsp; Our pipeline of products contains Medical Devices (Class IIA), food supplements, food for special medical purposes and dermo-cosmetics. We are constantly looking for partners from all over the world who share our values and are looking to distribute our finished products among their territories. We carefully select our partners in order to maintain highest standards in technology, competence, reliability and competitiveness. We have innovative products with patented formulations and our partner will have the possibility to customize our therapeutic solutions with their brand, our FDF have high quality MADE IN ITALY.&nbsp; Pizeta Pharma SpA has the quality system certification DNV-GL ISO 9001:2015 and it is able to guarantee all best service and collaboration for a win-win partnership with clients.

Pizeta Pharma S.p.A

ProBiotix Health Ltd is a division of the UK-based and London Stock traded Optibiotix (AIM: OPTI) focused on commercializing clinically validated nutraceuticals for Cardiovascular Disease on a global scale. 50% of all deaths in Europe and the US are caused by some kind of cardiovascular disease and 80% are believed to be preventable. We have developed the patented CholBiome&reg; portfolio with EFSA Health claims, human clinical studies, 2-year stab. studies acc. to ICH standards and leading probiotic players like Seed Health, Actial Farmaceutici, and Alfa Sigma have incorporated our patented probiotic technology in their finished products.

ProBiotix Health 

&bdquo;Inspired by nature&ldquo;
 Repha GmbH Biologische Arzneimittel is a medium-sized, family-run and research-based company based in Langenhagen near Hanover, Germany. Founded in 1925, Repha started developing unique herbal remedies.&nbsp;
&nbsp;
 Today it is a strong, future-oriented and dynamic family company with a long tradition. With experience and passion, it dedicates itself to our medicinal plants with a focus on unique combinations to help people with acute and chronic illnesses to stay or become healthy. The cultivation of its medicinal plants and the production of the preparations are carried out responsibly and with a high-quality standard (GMP).
&nbsp;
 Reliability, trust and fairness are important to Repha. They work close with pharmacies, doctors and alternative practitioners, scientists and partners in the healthcare sector. They listen to the users and learn from their experiences with the companies remedies. The preparations (Angocin, Myrrhinil-Intest, Nortase and many more) are used beyond national borders by patients whose well-being determines our daily actions. They are focused on the treatment of infections in the respiratory tract, urinary tract and gastrointestinal diseases.&nbsp;
Research spirit drives Repha. They promote Germany as a research location. It is their strength to scientifically confirm empirical medicine and to further develop it intensively. That is why they advocate the integration of naturopathy into medical treatment, because they are deeply convinced of its benefits for people.

Repha

Rosemont have over 50 years dedicated experience in developing oral liquid medicines, both licensed and unlicensed &lsquo;specials&rsquo;, across a range of therapeutic categories. At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines.

Rosemont Pharmaceuticals 

S-LAB is a pharmaceutical company located in Poland with 18 years of experience in the areas: Ophthalmology (OTC and medical devices). Cold remedies, Digestive &amp; Urinary tracts, Cardiology. We have our own sterile eye drops without preservatives facility, a sterile ointment facility, and a sterile wet wipes facility. We are experts in niche high-value medical devices and nutraceuticals in the field of ophthalmology and cold remedies. We are the second player in OTC Ophthalmology and one of the largest players in cold remedies products\r\non our Polish market.

S-LAB

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Basel, Switzerland.

Sandoz

Seltfar LTD is a privately held pharmaceutical company specialized in the registration, marketing, and promotion of medicines, medical devices, food supplements, and other medical products. The company's headquarters is located in the UK and its main activities are focused on the market of Kazakhstan and other CIS countries.
Link to the website: http://seltfar.co.uk&nbsp;

Seltfar 

Symphar is a dynamically growing middle-size pharmaceutical company in Poland, offering a range of Rx and OTC products, food supplements, and medical devices. We are engaged in Licensing-in of Rx and OTC products, sold under our own trademarks. Import and distribution of original branded products.
Areas of interest: Diabetology, psychiatry, neurology, urology, gynecology. Rx, OTC, medical devices, and food supplements.
&nbsp;

Symphar 

TargEDys&reg; is commercial-stage French biotech specialized in the development of nutraceutical solutions for the control of appetite through microbiome interventions. The company is the fruit of 15 years of research on microbiota conducted within academic laboratories. The company developed and started the commercialization of its first product based on the precibiomic or precision probiotic strain Hafnia alvei HA4597&trade; which efficacy in weight and appetite has been clinically demonstrated. Targedys&reg; develops a product portfolio focusing on overweight, undernutrition, and mental health, all based on the concept of precibiomic strains backed by a molecular mechanism of action and in vivo studies.

TargEDys

THAFF supports companies in developing their businesses, managing their projects, developing their product pipelines, marketing and selling self-medication products&nbsp;

THAFF Healthcare Consulting

We are one of the UK's fastest-growing, leading producers of OTC healthcare and household products, and own some of the country's most loved brands such as Covonia&reg;, Hedrin&reg;, Cetraben&reg; as well as the leading disinfectant Zoflora&reg;.

Thornton & Ross

UNOLAB is a laboratory dedicated to the manufacture of sterile unidose solutions to third parties, using the most advanced technology in the market. In UNOLAB, we are focused on providing a comprehensive service, from the purchase of raw materials to the delivery of the product fully conditioned and personalized customer.
&nbsp;

Unolab Manufacturing

Velit is part of a Group including 3 companies.&nbsp;
Velit Bioharma = Development&amp; Licensing in-out international
Nanovector = R&amp;D in nano-microlipids
Sintesi Pharma= Marketing&amp; Sales of Generics in Italy

Velit Biopharmaceuticals

VIANEX S.A. was established in 1924 and has the leading position in the Greek Pharmaceutical market.&nbsp;
Our sales for 2020 were 371 million Euros.
A key factor of our growth is the successful and long-lasting relations with firms of international reputation that are our partners: Merck &amp; Co (USA, since 1983), Sanofi Pasteur, Takeda (for more than 40 years), LFB International, Biotest etc. Our company consists of 1.256 employees, 445 of them working as salesmen and marketers. &nbsp;We have an excellent distribution department, and we distribute the products of each firm we represent to all pharmaceutical wholesalers (110), all State Hospitals (150) and all pharmaceutical cooperatives. We also sell to the main pharmacies all over Greece. (6,000 pharmacies from the total existing today 9,000).
&nbsp;
 Furthermore, VIANEX SA has 4 fully specialized manufacturing plants. Each plant is dedicated to the production of specialized pharmaceutical forms. Since 2005, VIANEX SA started exporting and Toll Manufacturing.&nbsp;
We also have our affiliate company VIAN for the marketing and distribution of OTC/FS products. VIAN is a fully integrated company offering to our partners a specialized branding process, pharmacy and medical call, regulatory, marketing, promotion, distribution.
The aim of VIANEX SA is to provide Pharmaceutical Companies with a network of professional Sales, Marketing, Regulatory and Medical Services in specific therapeutic areas in which we have proven expertise and which form a part of our future strategic objectives.&nbsp;
Only very recently, in July 2019 VIANEX SA Group acquired the Company PHARMANEL SA which has an important portfolio and specialization in this field of generic and generic plus products. This investment confirms the principles governing the operation of VIANEX for continuous expansion.

Vianex

Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.
&nbsp;

Zentiva Pharma UK

<ul>
<li>Post-pandemic transformation: what are the key trends, challenges, and opportunities for pharma companies focusing on OTC and primary care products?&nbsp;</li>
<li>Overview of consumer trends, consumption and pricing developments that are affecting portfolio decisions and geo-market opportunities</li>
</ul>

Agenda

Speakers.css-1f6omqm{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;margin-left:0.8rem;}19 Speakers

Franziska Katterbach

Helio Marcelo Segouras

João Ribeiro

Juliana Mazza Reis

Antonio Nardi

Ekrem Turajlić

Can Adamoglu

Marianne Hundtofte Nielsen

Jennifer Wang

Mayank Mathuriya

Olivier Reinhard

Ridvan Karacagil

Keith Strachan

Thomas Heil

Fabian Riess

Lisa Haag

Thomas Haffner

Kristina Dutchak

Francesco Rimoli

Lynx2Market.css-7303n9{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;color:#FFFFFF;margin-left:0.8rem;font-weight:400;}73 Lynx2Market